ERBB2 and breast cancer: Interestingly, higher levels of circulating miR-375 were linked to negative ER/PR status, positive HER2 status, and inflammatory BC, whereas higher levels of circulating miR-122 were associated with HER2-negative and non-inflammatory tumors (Tables 2 and Additional file 3: S3).